Skip to main content
SpringerLink
Log in

Introduction to Alzheimer's Disease

  • Protocol
Alzheimer's Disease

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 32))

Abstract

In 1907, Alois Alzheimer published an account (1) of a 51-year-old female patient, Auguste D., who suffered from strong feelings of jealousy towards her husband, increased memory impairment, disorientation, hallucinations, and often loud and aggressive behavior. After four and a half years of rapidly deteriorating mental illness, Auguste D died in a completely demented state. Postmortem histological analysis of her brain using the Bielschowsky silver technique revealed dense bundles of unusual fibrils within nerve cells (neurofibrillary tangles or NFTs) and numerous focal lesions within the cerebral cortex, subsequently named “senile plaques” by Simchowicz (2) Fig. 1). This combination of progressive presenile dementia with senile plaques and neurofibrillary tangles came to be known as Alzheimer’s disease (AD), a term that was later broadened to include senile forms of dementia with similar neuropathological findings. It was Divry (3) who first demonstrated the presence of amyloid at the center of the senile plaque, by means of Congo red staining. All amyloid deposits were originally thought to be starch-like in nature (hence the name), but it is now apparent that they are formed from a variety of different peptides and proteins (the latest count being 18). All amyloid share the property of a characteristic birefringence under polarized light after staining with Congo red dye, which is due to the presence of well-ordered 10 nm fibrils. The underlying protein component of these fibrils invariably adopts predominantly an antiparallel β-pleated sheet configuration. Ultrastructural observations have confirmed that the core of the senile plaque consists of large numbers of closely-packed, radiating fibrils, similar in appearance to those seen in other forms of amyloidosis (4,5), and have also revealed the presence of paired helical filaments (PHFs) within the NFTs (6). However, it took more than 50 yr from Divry’s original observation to determine the precise chemical nature of the senile plaque amyloid. Many neuropathologists have regarded this amyloid as a “tombstone” (an inert bystander) of AD. However, the advent of molecular genetics has finally and firmly established the central role of amyloid in the pathogenesis of the disease, although this is still disputed by some workers in the field. This introductory chapter is written in support of what has become known as the “amyloid cascade” hypothesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alzheimer, A. (1907) Uber eine eigenartige Erkankung der Hirnrinde. Allg. Zschr. f Psychiatr. Psychisch-Gerichtl. Mediz. 64, 146–148.

    Google Scholar 

  2. Simchowicz, T. (1911) Histologische Studien uber der senile Demenz. NisslAlzheimer Histologische histopathologische. Arbeiten 4/2, 267–444.

    Google Scholar 

  3. Divry, P. (1927) Etude histochemique des plaques seniles. J. Neurol. Psychiatry 27, 643–657.

    Google Scholar 

  4. Kidd, M. (1964) Alzheimer’s disease: an electron microscopical study. Brain 87, 307–320.

    CAS  PubMed  Google Scholar 

  5. Terry, R. D., Gonatas, H. K., and Weiss, M. (1964) Ultrastructural studies in Alzheimer’s presenile dementia. Am. J. Pathol. 44, 269–297.

    CAS  PubMed  Google Scholar 

  6. Kidd, M. (1963) Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature 97, 192–193.

    Google Scholar 

  7. Allsop, D., Landon, M., and Kidd, M. (1983) The isolation and amino acid composition of senile plaque core amyloid. Brain Res. 259, 348–352.

    CAS  PubMed  Google Scholar 

  8. Selkoe, D. J., Ihara, Y., and Salazar, F. J. (1982) Alzheimer’s disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulphate and urea. Science 215, 1243–1245.

    CAS  PubMed  Google Scholar 

  9. Glenner, G. G. and Wong, C. W. (1984) Alzheimer’s disease: initial report of the purification and characterisation of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885–890.

    CAS  PubMed  Google Scholar 

  10. Wong, C. W., Quaranta, V., and Glenner, G. G. (1985) Neuritic plaques and cerebrovascular amyloid in Alzheimer’s disease are antigenically related. Proc. Natl. Acad. Sci. USA 82, 8729–8732.

    CAS  PubMed  Google Scholar 

  11. Allsop, D., Landon, M., Kidd, M., Lowe, J. S., Reynolds G. P., and Gardner, A. (1986) Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer’s disease. Neurosci. Lett. 68, 252–256.

    CAS  PubMed  Google Scholar 

  12. Ikeda, S. I., Wong, C. W., Allsop, D., Landon, M., Kidd, M., and Glenner, G. G. (1987) Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer’s disease with an anti-β protein monoclonal antibody. Lab. Invest. 57, 446–449.

    CAS  PubMed  Google Scholar 

  13. Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M., and Selkoe, D. J. (1987) Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 84, 6953–6957.

    CAS  PubMed  Google Scholar 

  14. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., and Binder, L. I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913–4917.

    CAS  PubMed  Google Scholar 

  15. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986) Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 83, 4044–4048.

    CAS  PubMed  Google Scholar 

  16. Lee, V. M.-Y., Balin, B. J., Otvos, L., and Trojanowski, J. Q. (1991) A68, a major subunit of paired helical filaments and derivatized froms of normal tau. Science 251, 675–678.

    CAS  PubMed  Google Scholar 

  17. Wischik, C. M., Novak, M., Thogersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., et al. (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA 85, 4506–4510.

    CAS  PubMed  Google Scholar 

  18. Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., and Crowther, R. A. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550–553.

    CAS  PubMed  Google Scholar 

  19. Goedert, M., Spillantini, M. G., Cairns, N. J., and Crowther, R. A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159–168.

    CAS  PubMed  Google Scholar 

  20. Goedert, M. (1996) Tau protein and the neurofibrillary pathology of Alzheimer’s disease. Ann. NY Acad. Sci. 777, 121–131

    CAS  PubMed  Google Scholar 

  21. Matsuo, E. S., Shin, R.-W., Billingsley, M. L., Van de Voorde, A., O′Connor, M., Trojanowski, J. Q., et al. (1994) Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer’s disease paired helical filament tau. Neuron 13, 989–1002.

    CAS  PubMed  Google Scholar 

  22. Consensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”; (1998) Neurobiol. Aging 19.

    Google Scholar 

  23. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., et al. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733–736.

    CAS  PubMed  Google Scholar 

  24. Ponte, P., Gonzalez-DeWhitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg B., et al. (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331, 525–527.

    CAS  PubMed  Google Scholar 

  25. Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., and Ito, H. (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331, 530–532.

    CAS  PubMed  Google Scholar 

  26. Sandbrink R., Masters, C. L., and Beyreuther, K. (1994) βA4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons. J. Biol. Chem. 269, 1510–1517.

    CAS  PubMed  Google Scholar 

  27. deSauvage, F. and Octave, J. N. (1989) A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science 245, 651–653.

    CAS  Google Scholar 

  28. Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Olersdorf, T., et al. (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 1122–1124.

    CAS  PubMed  Google Scholar 

  29. Anderson, J. P., Esch, F. S., Keim, P. S., Sambamurti, K., Lieberberg, I., and Robakis N. K. (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci. Lett. 128, 126–128.

    CAS  PubMed  Google Scholar 

  30. Palmert, M. R., Siedlak, S. L., Podlisny, M. B., Greenberg, B., Shelton, E. R., Chan, H. W., et al. (1989) Soluble derivatives of the β amyloid protein precursor of Alzheimer’s disease are labeled by antisera to the β amyloid protein. Biochem. Biophys. Res. Commun. 165, 182–188.

    CAS  PubMed  Google Scholar 

  31. Kennedy, H. E., Kametani, F., and Allsop D. (1992) Only kunitz-inhibitor-containing isoforms of secreted Alzheimer amyloid precursor protein show amyloid immunoreactivity in normal cerebrospinal fluid. Neurodegeneration. 1, 59–64.

    Google Scholar 

  32. Seubert, P., Oltersdorf, T., Lee, M. G., Barbour, R., Blomquist, C., Davis, D. L., et al. (1993) Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361, 260–263.

    CAS  PubMed  Google Scholar 

  33. Estus, S., Golde, T. E., Kunishita, T., Blades, D., Lowery, D., Eisen, M., et al. (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255, 726–728.

    CAS  PubMed  Google Scholar 

  34. Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., et al. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322–325.

    CAS  PubMed  Google Scholar 

  35. Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., et al. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 1992 258, 126–129.

    CAS  PubMed  Google Scholar 

  36. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., et al. (1992) Isolation and quantification of soluble Alzheimer’s β-peptide from biological fluids. Nature 359, 325–327.

    CAS  PubMed  Google Scholar 

  37. Ghiso, J., Calero, M., Matsubara, E., Governale, S., Chuba, J., Beavis R., et al. (1997) Alzheimer’s soluble amyloid β is a normal component of human urine. FEBSLett. 408, 105–108.

    CAS  Google Scholar 

  38. Asami-Odaka, A., Ishibashi, Y., Kikuchi, T., Kitada, C., and Suzuki, N. (1995) Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 34, 10,272–10,278.

    CAS  PubMed  Google Scholar 

  39. Parvathy, S., Hussain, I., Karran, E. H., Turner, A. J., and Hooper, N. M. (1998) Alzheimer’s amyloid precursor protein α-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry 37, 1680–1685.

    CAS  PubMed  Google Scholar 

  40. Ishiura, S., Tsukahara, T., Tabira, T., and Sugita, H. (1989) Putative N-terminal splitting enzyme of amyloid A4 peptides is the multicatalytic proteinase, ingensin, which is widely distributed in mammalian cells. FEBS Lett. 257, 388–392.

    CAS  PubMed  Google Scholar 

  41. Nelson, R. B., Siman, R., Iqbal, M. A., and Potter, H. (1993) Identification of a chymotrypsin-like mast cell protease in rat brain capable of generating the N-terminus of the Alzheimer amyloid β-protein. J. Neurochem. 61, 567–577.

    CAS  PubMed  Google Scholar 

  42. Sahasrabudhe, S. R., Brown, A. M., Hulmes, J. D., Jacobsen, J. S., Vitek, M. P., Blume, A. J., and Sonnenberg, J. L. (1993) Enzymatic generation of the amino terminus of the β-amyloid peptide. J. Biol. Chem. 268, 16699–16705.

    CAS  PubMed  Google Scholar 

  43. Savage, M. J., Iqbal, M., Loh, T., Trusko, S. P., Scott, R., and Siman, R. (1994) Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the β-amyloid precursor protein. Neuroscience 60, 607–619.

    CAS  PubMed  Google Scholar 

  44. McDermott, J. R., Biggins, J. A. and Gibson, A. M. (1992) Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer β-amyloid protein from its precursor. Biochem. Biophys. Res. Commun. 185, 746–752.

    CAS  PubMed  Google Scholar 

  45. Chevallier, N., Jiracek, J., Vincent, B., Baur, C. P., Spillantini, M. G., Goedert, M., et al. (1997) Examination of the role of endopeptidase 3.4.24. 15 in Aβ secretion by human transfected cells. Br. J. Pharmacol. 121, 556–562.

    CAS  PubMed  Google Scholar 

  46. Ladror, U. S., Snyder, S. W., Wang, G. T., Holzman, T. F., and Krafft, G. A. (1994) Cleavage at the amino and carboxyl termini of Alzheimer’s amyloid-β by cathepsin D. J. Biol. Chem. 269, 18,422–18,428.

    CAS  PubMed  Google Scholar 

  47. Saftig, P., Peters, C., Von Figura, K., Craessaerts, K., Van Leuven, F., and De Strooper, B. (1996) Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J. Biol. Chem. 271, 27,241–27,244.

    CAS  PubMed  Google Scholar 

  48. Higaki, H., Quon, D., Zhong, Z., and Cordell, B. (1995) Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron 14, 651–659.

    CAS  PubMed  Google Scholar 

  49. Allsop, D., Christie, G., Gray, C., Holmes, S., Markwell, R., Owen, D., et al. (1997) Studies on inhibition of β-amyloid formation in APP751-transfected IMR-32 cells and SPA4CT-transfected SHSY5Y cells, in Alzheimer’s Disease: Biology, Diagnostics and Therapeutics (Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. and Wisniewski, H. M., eds.), Wiley, New York, pp. 717–727.

    Google Scholar 

  50. Citron, M., Diehl, T. S., Gordon, G., Biere, A. L., Seubert, P., and Selkoe, D. J. (1996) Evidence that the 42-and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93, 13,170–13,175.

    CAS  PubMed  Google Scholar 

  51. Klafki, H., Abramowski, D., Swoboda, R., Paganetti, P. A., and Staufenbiel, M. (1996) The carboxyl termini of β-amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities. J. Biol. Chem. 271, 28655-28659.

    Google Scholar 

  52. Christie, G., Markwell, R. E., Gray, C. W., Smith, L., Godfrey, F., Mansfield, F., et al. (1999) Alzheimers disease: correlation of the suppression of β-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome. J. Neurochem. in press.

    Google Scholar 

  53. Ishiura, S. (1991) Proteolytic cleavage of the Alzheimer’s disease amyloid A4 precursor protein. J. Neurochem. 56, 363–369

    CAS  PubMed  Google Scholar 

  54. Evin, G., Cappai, R., Li, Q. X., Culvenor, J. G., Small, D. H., Beyreuther, K., and Masters, C. L. (1995) Candidate γ-secretases in the generation of the carboxyl terminus of the Alzheimer’s disease βA4 amyloid: possible involvement of cathepsin D. Biochemistry 34, 14185–14192

    CAS  PubMed  Google Scholar 

  55. Weidemann, A., Konig, G., Bunke, D., Fischer, P., Salbaum, J. M., Masters, C. L. and Beyreuther, K. (1989) Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 57, 115–126.

    CAS  PubMed  Google Scholar 

  56. Hartmann, T., Bieger, S. C., Bruhl, B., Tienari, P. J., Ida, N., Allsop, D., et al. (1997) Distinct sites of intracellular production for Alzheimer’s disease Aβ 40/42 amyloid peptides. Nature (Med.) 3, 1016–1020

    Google Scholar 

  57. Whitson, J. S., Selkoe, D. J., and Cotman, C. W. (1989) Amyloid β-protein enhances the survival of hippocampal neurons in vitro. Science 243, 1488–1490.

    CAS  Google Scholar 

  58. Whitson, J. S., Glabe, C. G., Shintani, E., Abcar, A., and Cotman, C. W. (1990) β-amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110, 319–324.

    CAS  PubMed  Google Scholar 

  59. Yankner, B. A., Duffey, L. K., and Kirschner, D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein. Reversal by tachykinin neuropeptides. Science 250, 279–281.

    CAS  PubMed  Google Scholar 

  60. Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1991) In vitroaging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311–314.

    CAS  PubMed  Google Scholar 

  61. Yan, S. D., Chen X. Fu J., Chen, M., Zhu, H., Roher, A., Slattery, T., et al. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer’s disease. Nature 382, 685–691.

    CAS  PubMed  Google Scholar 

  62. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T. (1997) Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119–125

    CAS  PubMed  Google Scholar 

  63. Roher, A. E., Chaney, M. O., Kuo, Y. M., Webster, S. D., Stine, W. B., Haverkamp, L. J., et al. (1996) Morphology and toxicity of Aβ (1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer’s disease. J. Biol. Chem. 271, 20631–20635.

    CAS  PubMed  Google Scholar 

  64. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermedi-ate. J. Biol. Chem. 272, 22364–22372.

    CAS  PubMed  Google Scholar 

  65. Geula, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., and Yankner, B. A. (1998) Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med. 4, 827–831.

    CAS  PubMed  Google Scholar 

  66. Eikelenboom, P., Zhan, S. S., van-Gool, W. A., and Allsop, D. (1994) Inflammatory mechanisms in Alzheimer’s disease. Trends Pharmacol. Sci. 15, 447–450.

    CAS  PubMed  Google Scholar 

  67. Webster, S., Bonnell, B., and Rogers, J. (1997) Charge-based binding of complement component C 1 q to the Alzheimer amyloid β-peptide. Am. J. Pathol. 150, 1531–1536.

    CAS  PubMed  Google Scholar 

  68. Webster, S., Bradt, B., Rogers, J., and Cooper, N. (1997) Aggregation state-dependent activation of the classical complement pathway by the amyloid β peptide. J. Neurochem. 69, 388–398.

    CAS  PubMed  Google Scholar 

  69. El-Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., and Loike, J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716–719.

    CAS  PubMed  Google Scholar 

  70. Paresce, D. M., Ghosh R. N., and MaxfieldF. R. (1996) Microglial cells internalize aggregates of the Alzheimer’s disease amyloid β-protein via a scavenger receptor. Neuron 17, 553–565.

    CAS  PubMed  Google Scholar 

  71. Mattson, M. (1997) Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081–1132.

    CAS  PubMed  Google Scholar 

  72. Nishimoto, I., Okamoto, T., Matsuura, Y., Takahashi, S., Okamoto, T., Murayama, Y., and Ogata, E. (1993) Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(0). Nature 362, 75–79.

    CAS  PubMed  Google Scholar 

  73. VanNostrand, W. E., Wagner, S. L., Suzuki, M., Choi, B. H., Farrow, J. S., Geddes, J. W., Cotman, C. W., and Cunningham, D. D. (1989) Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid β-protein precursor. Nature 341, 546–549.

    CAS  Google Scholar 

  74. Smith, R. P., Higuchi, D. A., and Broze, G. J. J. (1990) Platelet coagulation factor Xia-inhibitor, a form of Alzheimer amyloid precursor protein. Science 248, 1126–1128.

    CAS  PubMed  Google Scholar 

  75. Miyazaki, K., Hasegawa, M., Funahashi, K., and Umeda, M. (1993)Ametalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 362, 839–841.

    CAS  PubMed  Google Scholar 

  76. Allsop, D., Clements, A., Kennedy, H., Walsh, D., and Williams, C. (1994) Mechanism of cerebral amyloidosis in Alzheimer’s disease, in Amyloid Protein Precursor in Development, Aging and Alzheimer’s Disease (Masters, C. L., Beyreuther, K., Trillet M., and Christen, Y., eds.), Springer-Verlag, Berlin, pp. 47–59.

    Google Scholar 

  77. Multhaup G., Mechler, H., and Masters, C. L. (1995) Characterization of the high affinity heparin binding site of the Alzheimer’s disease βA4 amyloid precursor protein (APP) and its enhancement by zinc(II). J. Mol. Recognit. 8, 247–57.

    CAS  PubMed  Google Scholar 

  78. Beher, D., Hesse, L., Masters, C. L., and Multhaup, G. (1996) Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J. Biol. Chem. 271, 1613–1620.

    CAS  PubMed  Google Scholar 

  79. Ghiso, J. A., Rostagno, J. E., Gardella, L., Liem, P. D., Gorevic, P. D., and Frangione, B. (1992) A 109-amino-acid C-terminal fragment of Alzheimer’s-disease amyloid precursor protein contains a sequence,-RHDS-, that promotes cell adhesion. Biochem. J. 288, 1053–1059.

    CAS  PubMed  Google Scholar 

  80. Breen, K. C., Bruce, M., and Anderton, B. H. (1991) Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J. Neurosci. Res. 28, 90–100.

    CAS  PubMed  Google Scholar 

  81. Ninomiya, H., Roch, J. M., Sundsmo, M. P., Otero, D. A., and Saitoh, T. (1993) Amino acid sequence RERMS represents the active domain of amyloid β/A4 protein precursor that promotes fibroblast growth. J. Cell Biol. 121, 879–886.

    CAS  PubMed  Google Scholar 

  82. Jin, L. W., Ninomiya, H., Roch, J. M., Schubert, D., Masliah, E., Otero, D. A., and Saitoh, T. (1994) Peptides containing the RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14, 5461–5470.

    CAS  PubMed  Google Scholar 

  83. Ninomiya, H., Roch, J. M., Jin, L. W. and Saitoh, T. (1994) Secreted form of amyloid β/A4 protein precursor (APP) binds to two distinct APP binding sites on rat B103 neuron-like cells through two different domains, but only one site is involved in neuritotropic activity. J. Neurochem. 63, 495–500.

    CAS  PubMed  Google Scholar 

  84. Goodman, Y. and Mattson, M. P. (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128, 1–12.

    CAS  PubMed  Google Scholar 

  85. Mattson, M. P., Cheng, B., Culwell, A. R., Esch, F. S., Lieberburg, I., and Rydel, R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron (1993) 10, 243–254.

    CAS  PubMed  Google Scholar 

  86. Smith-Swintosky, V. L., Pettigrew, L. C., Craddock, S. D., Culwell, A. R., Rydel, R. E., and Mattson, M. P. (1994) Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63, 781–784.

    CAS  PubMed  Google Scholar 

  87. Masliah, E., Westland, C. E., Rockenstein, E. M., Abraham, C. R., Mallory, M., Veinberg, I., et al. (1997) Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience 78, 135–146.

    CAS  PubMed  Google Scholar 

  88. Ohsawa I., Takamura, C., and Kohsaka, S. (1997) The amino-terminal region of amyloid precursor protein is responsible for neurite outgrowth in rat neocortical explant culture. Biochem. Biophys. Res. Commun. 236, 59–65.

    CAS  PubMed  Google Scholar 

  89. Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., Martin, G. M., et al. (1996) Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882–1894.

    CAS  PubMed  Google Scholar 

  90. Hardy, J. and Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol. Sci. 12, 383–388.

    CAS  PubMed  Google Scholar 

  91. Levy E., Carman, M. D., Fernandez-Madrid I. J., Power, M. D., Lieberburg I., van-Duinen, S. G., et al. (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248 (4959), 1124–1126.

    CAS  PubMed  Google Scholar 

  92. Wisniewski T., Ghiso, J., and Frangione, B. (1991) Peptides homologous to the amyloid protein of Alzheimer’s disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179, 1247–1254.

    CAS  PubMed  Google Scholar 

  93. Clements, A., Walsh, D. M., Williams, C. H., and Allsop, D. (1993) Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer’s amyloid β/A4 peptide. Neurosci. Lett. 161, 17–20.

    CAS  PubMed  Google Scholar 

  94. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704–706.

    CAS  PubMed  Google Scholar 

  95. Chartier-Harlin M. C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., et al. (1991) Early-onset Alzheimer’s disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353, 844–846.

    CAS  PubMed  Google Scholar 

  96. Murrell, J., Farlow, M., Ghetti, B., and Benson, M. D. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254, 97–99.

    Google Scholar 

  97. Younkin, S. G. (1995) Evidence that Aβ 42 is the real culprit in Alzheimer’s disease. Ann. Neurol. 37, 287–288.

    CAS  PubMed  Google Scholar 

  98. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., et al. (1992) Assembly and aggregation properties of synthetic Alzheimer’s A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546–554.

    CAS  PubMed  Google Scholar 

  99. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., et al. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer’s disease increases β-protein production. Nature 360, 672–674.

    CAS  PubMed  Google Scholar 

  100. Cai, X. D., Golde, T. E., and Younkin, S. G. (1993) Release of excess amyloid P protein from a mutant amyloid β protein precursor. Science 259, 514–516.

    CAS  PubMed  Google Scholar 

  101. Clements, A., Allsop, D., Walsh, D. M., and Williams, C. H. (1996) Aggregation and metal-binding properties of mutant forms of the amyloid Aβ peptide of Alzheimer’s disease. J. Neurochem. 66, 740–747.

    CAS  PubMed  Google Scholar 

  102. Haass, C., Hung, A. Y., Selkoe, D. J., and Teplow, D. B. (1994) Mutations associated with a locus for familial Alzheimer’s disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269, 17741–17748.

    CAS  PubMed  Google Scholar 

  103. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375, 754–760.

    CAS  PubMed  Google Scholar 

  104. Levy-Lahad, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269, 973–977.

    CAS  PubMed  Google Scholar 

  105. Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., et al. (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Aβ 1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005–1013.

    CAS  PubMed  Google Scholar 

  106. Mehta, N. D., Refolo, L. M., Eckman, C., Sanders, S., Yager, D., Perez-Tur, J., et al. (1998) Increased Aβ42(43) from cell lines expressing presenilin 1 mutations. Ann. Neurol. 43, 256–258.

    CAS  PubMed  Google Scholar 

  107. Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705.

    CAS  PubMed  Google Scholar 

  108. Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., et al. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815–825.

    CAS  PubMed  Google Scholar 

  109. Spillantini, M. G., Bird, T. D., and Ghetti, B. (1998) Frontotemporal dementia and Parkinsonism linked to chromosome 17: anew group of tauopathies. Brain Pathol. 8, 387–402.

    CAS  PubMed  Google Scholar 

  110. Busciglio, J., Lorenzo, A., Yeh, J., and Yankner, B. A. (1995) β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879–888.

    CAS  PubMed  Google Scholar 

  111. Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., and Imahori, K. (1996) Exposure of rat hippocampal neurons to amyloid β peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 β. Neurosci. Lett. 203, 33–36.

    CAS  PubMed  Google Scholar 

  112. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13,287–13,292.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biological Sciences, University of Lancaster, UK

    David Allsop

Authors
  1. David Allsop
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Leeds, Leeds, UK

    Nigel M. Hooper

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Allsop, D. (2000). Introduction to Alzheimer's Disease. In: Hooper, N.M. (eds) Alzheimer's Disease. Methods in Molecular Medicine™, vol 32. Humana Press. https://doi.org/10.1385/1-59259-195-7:1

Download citation

  • DOI: https://doi.org/10.1385/1-59259-195-7:1

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-737-3

  • Online ISBN: 978-1-59259-195-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation